manifestclinicaltrials.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: | ||
Meta Tags
| Title | Myelofibrosis Research Study – Now Enrolling | |
| Description | Investigating BET inhibitor pelabresib .css-1bmnxg7{white-space:nowrap;}(CPI-0610) in Manifest 2 is a research study investigating pelabresib, a potential treatment for myelofibrosis, in combination with ruxolitinib. View |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 104.198.14.52 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
manifestclinicaltrials.com Valuation
|
US$593,710
Last updated: 2023-05-07 13:48:53
manifestclinicaltrials.com has Semrush global rank of 17,827,420. manifestclinicaltrials.com has an estimated worth of US$ 593,710, based on its estimated Ads revenue. manifestclinicaltrials.com receives approximately 68,505 unique visitors each day. Its web server is located in United States, with IP address 104.198.14.52. According to SiteAdvisor, manifestclinicaltrials.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$593,710 |
| Daily Ads Revenue | US$549 |
| Monthly Ads Revenue | US$16,442 |
| Yearly Ads Revenue | US$197,295 |
| Daily Unique Visitors | 4,567 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| manifestclinicaltrials.com. 7198 IN | A | IP: 104.198.14.52 | |
| manifestclinicaltrials.com. 86400 IN | NS | NS Record: dns3.comlaude-dns.co.uk. | |
| manifestclinicaltrials.com. 86400 IN | NS | NS Record: dns4.comlaude-dns.eu. | |
| manifestclinicaltrials.com. 86400 IN | NS | NS Record: dns1.comlaude-dns.com. | |
| manifestclinicaltrials.com. 86400 IN | NS | NS Record: dns2.comlaude-dns.net. |
HtmlToTextCheckTime:2023-05-07 13:48:53
| Treating myelofibrosis About MANIFEST-2 Eligibility Why take part? Locations & how to enroll For US Healthcare Professionals Investigating BET inhibitor pelabresib (CPI-0610) in myelofibrosis Have you or a loved one recently been diagnosed with myelofibrosis (MF)? Learn about MANIFEST-2 , a Phase 3 clinical research study investigating pelabresib (CPI-0610) . Pelabresib is an investigational new drug not approved by any regulatory authority. There is no guarantee that it will be approved. Constellation Pharmaceuticals, Inc., a MorphoSys company, is the MANIFEST-2 trial sponsor. This content is intended for patients. If you are a healthcare professional, please click here. What is myelofibrosis and how is it currently treated? MF is a rare and complex form of bone marrow cancer that disrupts the normal production of blood cells in the body. People with MF may experience: Bone marrow fibrosis: a buildup of scar tissue in the bone marrow Splenomegaly: an enlarged spleen Severe anemia |
HTTP Headers
HTTP/1.1 301 Moved Permanently cache-control: public, max-age=0, must-revalidate content-length: 50 content-type: text/plain date: Thu, 28 Oct 2021 04:10:27 GMT x-nf-request-id: 01FK2HF2G69WF6NQ5C3S4RM40V location: https://manifestclinicaltrials.com/ server: Netlify age: 1 HTTP/2 301 cache-control: public, max-age=0, must-revalidate content-length: 54 content-type: text/plain date: Thu, 28 Oct 2021 04:10:27 GMT strict-transport-security: max-age=31536000 server: Netlify location: https://www.manifestclinicaltrials.com/ x-nf-request-id: 01FK2HF367K5ATWGQT0T56JQAG age: 0 HTTP/2 200 cache-control: public, max-age=0, must-revalidate content-type: text/html; charset=UTF-8 date: Wed, 27 Oct 2021 03:42:56 GMT etag: "990dc1b5afacbbebd116bf18da1fd709-ssl" strict-transport-security: max-age=31536000 content-length: 40333 age: 88051 server: Netlify x-nf-request-id: 01FK2HF3HEMV7TVH1JGJBT6DX3 |
manifestclinicaltrials.com Whois Information
Domain Name: MANIFESTCLINICALTRIALS.COM Registry Domain ID: 2572231316_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.comlaude.com Registrar URL: http://www.comlaude.com Updated Date: 2020-11-13T19:28:20Z Creation Date: 2020-11-13T19:28:20Z Registry Expiry Date: 2021-11-13T19:28:20Z Registrar: Nom-iq Ltd. dba COM LAUDE Registrar IANA ID: 470 Registrar Abuse Contact Email: abuse@comlaude.com Registrar Abuse Contact Phone: +442074218250 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: DNS1.COMLAUDE-DNS.COM Name Server: DNS2.COMLAUDE-DNS.NET Name Server: DNS3.COMLAUDE-DNS.CO.UK Name Server: DNS4.COMLAUDE-DNS.EU DNSSEC: unsigned >>> Last update of whois database: 2021-09-15T21:52:45Z <<< |